Inventor
TU YU-HSING
US53 patents
⚠️ This page may combine multiple inventors who share the name “TU YU-HSING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TRIS PHARMA INC
33 patentsUS9198864B2Dec 1, 2015
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC55 citations99
US8883217B2Nov 11, 2014
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC57 citations99
US8790700B2Jul 29, 2014
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC70 citations99
US8747902B2Jun 10, 2014
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC70 citations99
US8597684B2Dec 3, 2013
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC77 citations99
US8491935B2Jul 23, 2013
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC95 citations99
US10933143B2Mar 2, 2021
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC36 citations98
US10857143B2Dec 8, 2020
Methylphenidate extended release chewable tablet
TRIS PHARMA INC45 citations98
US10668163B2Jun 2, 2020
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC36 citations98
US10507203B2Dec 17, 2019
Methylphenidate extended release chewable tablet
TRIS PHARMA INC42 citations98
US10172958B2Jan 8, 2019
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC37 citations98
US10086087B2Oct 2, 2018
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC36 citations98
US9844544B2Dec 19, 2017
Methylphenidate extended release chewable tablet
TRIS PHARMA INC46 citations98
US9844545B2Dec 19, 2017
Methylphenidate extended release chewable tablet
TRIS PHARMA INC43 citations98
US9675703B2Jun 13, 2017
Modified release formulations containing drug - ion exchange resin complexes
TRIS PHARMA INC49 citations98
US9675704B2Jun 13, 2017
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC49 citations98
US9549989B2Jan 24, 2017
Modified release formulations containing drug-ion exchange resin complexes
TRIS PHARMA INC40 citations98
US9545399B2Jan 17, 2017
Methylphenidate extended release chewable tablet
TRIS PHARMA INC50 citations98
US9522191B2Dec 20, 2016
Modified release formulations containing drug—ion exchange resin complexes
TRIS PHARMA INC40 citations98
US9295642B2Mar 29, 2016
Methylphenidate extended release chewable tablet
TRIS PHARMA INC61 citations98
US9180100B2Nov 10, 2015
Methylphenidate extended release chewable tablet
TRIS PHARMA INC55 citations98
US9040083B2May 26, 2015
Orally effective methylphenidate extended release powder and aqueous suspension product
TRIS PHARMA INC51 citations98
US8999386B2Apr 7, 2015
Methylphenidate extended release chewable tablet
TRIS PHARMA INC56 citations98
US8956649B2Feb 17, 2015
Orally effective methylphenidate extended release powder and aqueous suspension product
TRIS PHARMA INC51 citations98
US8778390B2Jul 15, 2014
Orally effective methylphenidate extended release powder and aqueous suspension product
TRIS PHARMA INC62 citations98
US8563033B1Oct 22, 2013
Orally effective methylphenidate extended release powder and aqueous suspension product
TRIS PHARMA INC67 citations98
US9408823B2Aug 9, 2016
Benzonatate modified release solid tablets and capsules
TRIS PHARMA INC44 citations96
US9180104B2Nov 10, 2015
Benzonatate modified release solid tablets and capsules
TRIS PHARMA INC59 citations96
US9867797B2Jan 16, 2018
Benzonatate modified release solid tablets and capsules
TRIS PHARMA INC38 citations93
US11103495B2Aug 31, 2021
Methylphenidate extended release chewable tablet
TRIS PHARMA INC5 citations84
US11103494B2Aug 31, 2021
Methylphenidate extended release chewable tablet
TRIS PHARMA INC5 citations84
US11241411B2Feb 8, 2022
Benzonatate modified release solid tablets and capsules
TRIS PHARMA INC3 citations71
US11633389B2Apr 25, 2023
Methylphenidate extended release chewable tablet
TRIS PHARMA INC0 citations62
MEHTA KETAN
9 patentsUS8337890B2Dec 25, 2012
Modified release formulations containing drug-ion exchange resin complexes
MEHTA KETAN79 citations99
US8287903B2Oct 16, 2012
Orally effective methylphenidate extended release powder and aqueous suspension product
MEHTA KETAN88 citations99
US8202537B2Jun 19, 2012
Modified release formulations containing drug-ion exchange resin complexes
MEHTA KETAN94 citations99
US8062667B2Nov 22, 2011
Modified release formulations containing drug-ion exchange resin complexes
MEHTA KETAN119 citations99
US8623409B1Jan 7, 2014
Clonidine formulation
MEHTA KETAN60 citations98
US8465765B2Jun 18, 2013
Orally effective methylphenidate extended release powder and aqueous suspension product
MEHTA KETAN71 citations98
US8512688B2Aug 20, 2013
Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
MEHTA KETAN68 citations97
US8287848B2Oct 16, 2012
Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
MEHTA KETAN87 citations97
US8202542B1Jun 19, 2012
Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
MEHTA KETAN132 citations95
TULEX PHARMACEUTICALS INC
7 patentsUS12343372B2Jul 1, 2025
Desmopressin oral compositions
TULEX PHARMACEUTICALS INC2 citations72
US12214010B2Feb 4, 2025
Desmopressin oral compositions
TULEX PHARMACEUTICALS INC2 citations72
US11911362B2Feb 27, 2024
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC1 citations72
US11826343B2Nov 28, 2023
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC1 citations72
US11633374B2Apr 25, 2023
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC2 citations72
US11433046B2Sep 6, 2022
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC3 citations72
US12290503B2May 6, 2025
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC0 citations62
MEDEVA PHARMACEUTICALS MANUFAC
1 patentShowing the top 50 of 53 patents by PatentIndex Score.